Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway

Samadi, A.K., J. Bazzill, X. Zhang, R. Gallagher, H. Zhang, R. Gollapudi, K. Kindscher, B.N. Timmermann, and M.S. Cohen. 2012. Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway. Surgery 152:1238-47.